FREE SHIPPING on orders over $59 | 100% Happiness Guarantee | 📞 877-564-5756 | ✉️ info@bioabsorbnutraceuticals.com

Vitamin C for Older Adults: Absorption, Status, and Dosing

Vitamin C for Older Adults: Absorption, Status, and Dosing

Older adults eat about as much vitamin C as younger adults, and still end up with less of it in their blood.

That gap is visible in national survey data. Across 2,828 non-supplemented US adults, dietary vitamin C intake was similar in the 18–36, 37–58 and 59–80+ age groups, yet circulating concentrations were significantly lower in both older groups.

Here is what that gap actually means, where the real risk sits, and what the evidence supports for vitamin C after 60.

Key Takeaways

Table of Contents

  1. What Changes With Age, and What Doesn't
  2. Why Blood Levels Fall When Intake Doesn't
  3. The Bigger Divide Is Circumstance, Not Age
  4. How Much Vitamin C Do Older Adults Need?
  5. Immune Function and Infection in Later Life
  6. When Absorption Is the Bottleneck
  7. Corn-Free Vitamin C: Two Formats, Different Jobs
  8. Frequently Asked Questions
  9. Conclusion
  10. Research References

1. What Changes With Age, and What Doesn't

The most useful study on this question set out to test something specific: does the relationship between what you eat and what ends up in your blood shift as you get older? Researchers examined 2,828 non-supplemented adults from NHANES 2017–2018, split into three age tertiles — 18–36, 37–58 and 59–80+. Reported vitamin C intake was similar across all three. Circulating concentrations were not: they were significantly lower in the middle and older groups.

The interesting part is where that difference lived. Above an intake of 75mg/day, there was no significant difference between younger and older adults in how intake translated into serum concentration. Below 75mg/day, older adults had significantly lower serum levels for the same intake. The effect held among non-smokers and was made worse by smoking.

That is a narrower finding than "older adults absorb vitamin C poorly", and the difference matters. At reasonable intakes, the machinery appears to work about as well at 70 as at 30. It is at low intakes — the ones closest to the RDA of 90mg/day for men and 75mg/day for women — that the margin for error shrinks. The authors concluded that healthy ageing in non-institutionalised people does not, by itself, increase vitamin C requirements.

2. Why Blood Levels Fall When Intake Doesn't

Several mechanisms have been proposed for the age-related drop, and the honest position is that none has been confirmed in humans. A 2020 review summarising 36 publications reported that adults aged 60–96 had considerably lower plasma vitamin C than those aged 15–65 following a given intake, which points at absorption or clearance rather than diet. The candidate explanations are increased utilisation, faster turnover, reduced intestinal absorption, less efficient renal reabsorption, and reduced cellular uptake.

The cellular uptake theory has the most mechanistic support and the least human evidence. Vitamin C crosses the gut wall mainly through a sodium-dependent transporter called SVCT1, and animal work has reported that expression of this transporter declines with age. That is a plausible bridge to the human data, but pharmacokinetic studies comparing older and younger people directly have not been done. Treat it as a working hypothesis rather than an established fact.

Body composition contributes something too. Vitamin C distributes through lean tissue, and lean mass declines with age, so the same absorbed amount is diluted differently. Whatever the mix of causes, the practical consequence is the one covered in our guide to why most of your vitamin C dose is wasted: absorption efficiency runs at 70–90% at intakes of 30–180mg/day but falls below 50% above 1g/day, and the excess is excreted.

3. The Bigger Divide Is Circumstance, Not Age

This is the finding that should reorganise how you think about the topic. A systematic scoping review of comparative studies concluded there was limited evidence that healthy ageing on its own is related to lower vitamin C status or higher requirements. Institutionalised older people were a different story entirely: they had lower status and genuinely elevated requirements, driven by low intakes and chronic illness that hospital and residential diets were not meeting.

The numbers behind that split are stark. Around 40% of 423 people living in nursing or residential homes had deficient plasma vitamin C, with a mean of 24.4 µmol/L. A study of admissions to a geriatric assessment ward found vitamin C deficiency in 40.1% of patients, highest among those admitted from institutions, and reported that the standard hospital diet did not correct it in the short term. More recently, a scoping review of hospitalised adults in high-income countries put the cumulative prevalence of vitamin C deficiency at 27.7% across 2,494 patients (95% CI 21.3–34.0).

Frailty tracks with it. In 160 hospitalised patients with a mean age of 84.4 years, vitamin C deficiency was associated with moderate to severe frailty after adjustment for age, sex, comorbidity burden, smoking, nutritional risk, cognition and fruit intake. Association is not causation, and low vitamin C is as likely to be a consequence of illness as a contributor to it. The signs to watch for are covered in our guide to the signs and symptoms of vitamin C deficiency.

4. How Much Vitamin C Do Older Adults Need?

The official numbers do not change with age. The RDA remains 90mg/day for men and 75mg/day for women, with an extra 35mg/day for people who smoke, and the Tolerable Upper Intake Level stays at 2,000mg/day. Health Canada uses the same reference values. Only one country has set a higher figure specifically for older adults: France recommends 120mg/day for adults aged 75 and over.

What the research literature points to is more useful than the RDA. Daily intakes of 100–200mg generally produce plasma concentrations of 50–70 µmol/L, which is the adequate-to-saturating range. Below that, there are no internationally agreed cut-off values, but the most commonly used thresholds place hypovitaminosis C at roughly 23–28 µmol/L or below, with under 11 µmol/L signalling deficiency and rising scurvy risk. Given that the NHANES finding put the vulnerable zone below 75mg/day, aiming somewhere in the 100–200mg range puts comfortable distance between you and the edge.

A few practical points for this age group:

  • Splitting intake across two smaller servings absorbs better than one large one, because uptake saturates.
  • Anyone with reduced kidney function should speak to a physician before supplementing — the 2,000mg/day ceiling is not a target, and clearance changes with age.
  • Vitamin C substantially increases absorption of non-heme iron, which matters if you have an iron-overload condition such as haemochromatosis. The mechanism is covered in our guide to how vitamin C and iron absorption interact.
  • If you take regular medication — and nearly a quarter of the global disease burden falls on people aged 60 and over — raise supplementation with your prescriber rather than adding it silently.

5. Immune Function and Infection in Later Life

Immune cells concentrate vitamin C at levels far above plasma, and immune function declines with age, so the pairing gets a great deal of marketing attention. The evidence deserves a more careful reading than it usually gets, and we cover it in depth in our guide to what the research actually shows about vitamin C and immune function.

On colds, a 2023 meta-analysis of 15 comparisons from 10 placebo-controlled trials found that vitamin C reduced common cold severity by 15% (95% CI 9–21%). That is a real effect and a modest one, and those trials were run in generally healthy adults rather than specifically in older people. What we can say about vitamin C for colds and flu is bounded by that evidence base.

On pneumonia, which is a far more serious concern after 70, the Cochrane review found the evidence too limited to justify routine supplementation, while noting that effects may appear only in particular conditions — such as people who start with low vitamin C status. That caveat keeps pointing back to the same place. The population most likely to benefit is the one that is depleted to begin with, and among older adults that is disproportionately the institutionalised and the chronically unwell rather than the healthy 68-year-old.

6. When Absorption Is the Bottleneck

If the age-related gap sits in absorption rather than intake, delivery format becomes a reasonable question. Liposomal vitamin C wraps ascorbate in phospholipid vesicles, which is one approach to the saturable transporter bottleneck described earlier. A 2025 scoping review screened 321 studies, included 10, and found that nine of the ten reported higher uptake for liposomal ascorbate, with 1.3–7.2-fold higher AUC across formulations at doses ranging from 0.15g to 10g. Our complete guide to liposomal vitamin C works through that literature in detail.

Now the limitation, because it is directly relevant to this article. The participants in those trials had a mean baseline vitamin C status of roughly 50 µmol/L, which is already adequate. The review's own recommendation for future research is that studies should assess people with low baseline concentrations. Depleted older adults are exactly that group, and they have not been studied.

So the honest summary is two-part. The absorption advantage of liposomal delivery is well documented in adults with adequate status. Whether it produces better outcomes in depleted older adults specifically has not been tested, and anyone claiming otherwise is ahead of the evidence. What the absorption data does support is a narrower claim: if you are trying to move plasma concentration and standard forms are being excreted, the delivery format is a variable worth considering.

7. Corn-Free Vitamin C: Two Formats, Different Jobs

Commercial ascorbic acid is commonly produced from corn-derived glucose, and labels rarely disclose the source. For anyone managing a corn allergy or sensitivity, that turns a routine purchase into an investigation. Bio Absorb Nutraceuticals built its vitamin C line around verified corn-free sourcing, which is the differentiator worth knowing about.

The line comes in two formats sharing one formulation and one allergen profile, and the choice between them is genuinely practical for older adults. Liposomal Vitamin C Liquid 1000mg (Corn-Free) has a natural orange flavour and mixes into water or juice, which suits anyone who finds swallowing pills uncomfortable or who wants to split intake across the day. Liposomal Vitamin C Capsules 1000mg (Corn-Free) need no refrigeration, have no taste, and travel well — easier to fit into an existing medication routine.

Both use phospholipid encapsulation, and both are non-GMO, gluten-free, nut-free, dairy-free and vegan. Manufacturing happens in a GMP-certified facility in Canada, every batch is third-party tested, and the product is non-irradiated. Orders carry a 100% money-back guarantee with no requirement to return empty bottles. Both product pages carry current pricing and serving details.

Frequently Asked Questions

Do I need more vitamin C now that I am over 65?

Probably not, if you are in reasonable health and living independently. The scoping review evidence found limited support for the idea that healthy ageing raises vitamin C requirements. What changes is the consequence of a low intake — below 75mg/day, older adults show lower blood levels than younger adults eating the same amount.

Why are my blood levels low when my diet has not changed?

Because the intake-to-blood-level relationship shifts at the low end. NHANES data showed significantly lower serum vitamin C in adults aged 59–80+ despite similar reported intake. Reduced absorption, faster turnover, less efficient kidney reabsorption and lower lean mass have all been proposed, but no single mechanism has been confirmed in humans.

Should someone in a care home be supplemented?

This is where the evidence is strongest. Roughly 40% of residents in nursing and residential homes had deficient plasma vitamin C, and hospital and residential diets have repeatedly failed to correct it. It is a conversation to have with the care team or physician, not a decision to make unilaterally on someone else's behalf.

Is a liquid easier to absorb than a capsule?

Not meaningfully, in terms of absorption — both formats deliver the same liposomal formulation. The practical case for a liquid in this age group is different: it avoids swallowing a pill, mixes into a drink, and makes splitting intake across the day straightforward, which helps because absorption efficiency drops below 50% above 1g/day.

Can vitamin C interfere with my medications?

It can interact with a few things, and the relevant one for many older adults is iron. Vitamin C markedly increases non-heme iron absorption, which is unhelpful in haemochromatosis or other iron-overload conditions. Anyone with reduced kidney function, an iron-overload condition, or a long medication list should raise supplementation with their prescriber before starting.

Does liposomal vitamin C work better for older adults specifically?

That has not been tested. The 2025 scoping review found higher uptake in nine of ten trials, but participants had a mean baseline status around 50 µmol/L — already adequate — and the review explicitly names studies in people with low baseline concentrations as a gap. Depleted older adults are that untested group.

Conclusion

The picture that emerges is more specific and more useful than "older people need more vitamin C". Healthy, independent ageing does not appear to raise requirements much, but low intake becomes less forgiving after 60, and the 40% deficiency rate among residential care residents shows how sharply circumstance, not age, drives the risk. Getting to a steady 100–200mg/day matters more than chasing a large dose. If a corn allergy has made that difficult, Bio Absorb's verified corn-free Liposomal Vitamin C is available in a liquid format or a capsule format.

Research References

  1. Does Aging Affect Vitamin C Status Relative to Intake? Findings from NHANES 2017–2018. Nutrients, Vol. 15, Issue 4, Article 892 (2023). Found similar vitamin C intake but significantly lower circulating concentrations in older adults across 2,828 non-supplemented participants, with the difference confined to intakes below 75mg/day.
  2. Does Aging Have an Impact on Vitamin C Status and Requirements? A Scoping Review of Comparative Studies of Aging and Institutionalisation. Nutrients, Vol. 15, Issue 4, Article 915 (2023). Found limited evidence that healthy ageing raises vitamin C requirements, while identifying institutionalised older people as having genuinely lower status and elevated requirements.
  3. Prevalence, risk factors, and clinical outcomes of vitamin C deficiency in adult hospitalized patients in high-income countries: a scoping review. Nutrition Reviews, Vol. 82, Issue 11 (2024). Reported a cumulative vitamin C deficiency prevalence of 27.7% across 2,494 hospitalised patients.
  4. Prevalence of Hypovitaminosis C and its Relationship with Frailty in Older Hospitalised Patients: A Cross-Sectional Study. Nutrients, Vol. 13, Issue 6, Article 2117 (2021). Found vitamin C deficiency associated with moderate to severe frailty in 160 patients of mean age 84.4 years after multivariate adjustment.
  5. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, Article e70067 (2025). Screened 321 studies and included 10; nine reported higher uptake for liposomal ascorbate, with 1.3–7.2-fold higher AUC, and flagged the absence of trials in people with low baseline status.
  6. Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health, Vol. 23, Article 2468 (2023). Pooled 15 comparisons from 10 randomised double-blind trials and found a 15% reduction in common cold severity.
  7. Vitamin C status of elderly patients on admission into an assessment geriatric ward. Journal of International Medical Research, Vol. 15, Issue 2, pp. 96–98 (1987). Found vitamin C deficiency in 40.1% of admissions, highest among patients admitted from institutions, and not corrected by the standard hospital diet.
  8. The Contribution of Plasma and Brain Vitamin C on Age and Gender-Related Cognitive Differences: A Mini-Review of the Literature. Frontiers in Integrative Neuroscience, Vol. 14 (2020). Summarised evidence that 40% of 423 residential care residents had deficient plasma vitamin C averaging 24.4 µmol/L, and that adults aged 60–96 show lower plasma levels than younger adults at equivalent intakes.
  9. Vitamin C for preventing and treating pneumonia. Cochrane Database of Systematic Reviews, Issue 8, Art. No. CD005532 (2013). Concluded the evidence is too limited to support routine vitamin C supplementation for pneumonia, while noting possible effects in specific conditions.
  10. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements. Source for the 90mg and 75mg RDAs, the additional 35mg/day for smokers, the 2,000mg/day Tolerable Upper Intake Level, and absorption efficiency of 70–90% at 30–180mg/day falling below 50% above 1g/day.
  11. Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern?. Nutrients, Vol. 12, Issue 7, Article 2008 (2020). Notes that no internationally accepted cut-off values exist for vitamin C status, and that the most commonly applied thresholds are ≤23–28 µmol/L for hypovitaminosis C and ≤11 µmol/L for deficiency.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.


Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.